HOME >> BIOLOGY >> NEWS
Military to study better pain relief in battle zones

ANN ARBOR, Mich. University of Michigan scientists have received a pilot grant of nearly $1.3 million from the Defense Advanced Research Projects Agency to test whether nanoparticles can solve a pressing problem in battle zones like Iraq: how to administer sustained, safe doses of the most effective painkillers to injured soldiers, long before they can reach expert medical help.

The ultimate goal is to develop tiny drug-bearing particles that a fellow soldier or perhaps the injured soldier himself could inject with a pen-like device, even in the heat of combat. That would solve one of the challenges now. Morphine, an effective painkiller that the military commonly uses for the acute pain of battle injuries, currently needs to be injected by skilled medical personnel and has to be monitored carefully to control its troublesome tendency to suppress normal breathing.

This proposal provides an approach to achieve sustained, safe pain control on the battlefield, says the U-M research teams leader, James R. Baker, Jr., M.D., director of the Michigan Nanotechnology Institute for Medicine and Biological Sciences.

It uses different medicines coupled to polymers to release drugs and antidotes to provide adequate pain relief while avoiding complications. If successful, it could markedly improve the treatment of soldiers in the field, says Baker, the Ruth Dow Doan Professor of Internal Medicine in the U-M Medical School.

The work could have a broad impact. In the war in Iraq, more than 26,900 U.S. soldiers have been wounded in action as of late July. Its known that battlefield pain, if not relieved adequately, can lead to post-traumatic stress disorders.

A large multidisciplinary team of U-M scientists will use the grant to design multipurpose nanoparticles and test how well they perform several tasks under simulated physiological conditions in the laboratory. Ultimately, they want the particles to be able to:

    '"/>


Contact: Anne Rueter
arueter@umich.edu
734-764-2220
University of Michigan Health System
30-Jul-2007


Page: 1 2

Related biology news :

1. Military bases can benefit by addressing sprawl issues and biodiversity
2. Military hazards are greater for Native Americans, according to sociological research
3. New Military Biomaterials R&D Center to hold first meeting
4. New study warns limited carbon market puts 20 percent of tropical forest at risk
5. Clones on task serve greater good, evolutionary study shows
6. Pollution causes 40 percent of deaths worldwide, study finds
7. A study by the MUHC and McGill University opens a new door to understanding cancer
8. New study suggests Concord grape juice may provide protection against breast cancer
9. Preclinical study links gene to brain aneurysm formation
10. In limiting life span, study finds booming bacteria innocent
11. Multicenter study nets new lung tumor-suppressor gene

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/28/2020)... HOUSTON (PRWEB) , ... May 27, 2020 , ... CrucialTrak, ... will partner with New Jersey-based Critical Environments Group (CEG) to market and sell its ... provider of data center and IT environment infrastructure optimization solutions . , ...
(Date:5/26/2020)... ... May 26, 2020 , ... ... biopharmaceutical R&D, today announced that Gritstone Oncology, Inc., a clinical-stage biotechnology company ... cell engagers and TCR-based therapeutics, has implemented Genedata Biologics ® within ...
(Date:5/21/2020)... ... 20, 2020 , ... Catalent, the leading global provider of ... therapies, and consumer health products, today announced that Jean-François Chaubard, Senior Director, Open ... 2020 Paris Virtual conference, which takes place on 28 – 29 May, 2020. ...
Breaking Biology News(10 mins):
(Date:6/28/2020)... , ... June 25, 2020 , ... ... advance photodynamic therapy for treating cancer, today announced the company has entered a ... Park”). The agreement provides Lumeda globally exclusive rights to Roswell Park intellectual ...
(Date:6/23/2020)... ... June 23, 2020 , ... Kerafast ... bioresearch materials, today announced the availability of the Delta-G-VSV Pseudotyping System for coronavirus ... Tennessee, enables studies of SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just ...
(Date:6/23/2020)... ... June 22, 2020 , ... Regen Suppliers, the one stop ... buy three, get the fourth unit free with no limit on the amniotic ... as exosomes, have been a game changer for regenerative therapies. The products are ...
(Date:6/23/2020)... , ... June 23, 2020 , ... ... CNS therapies, today announced that it has filed an Investigational New Drug application ... 2b clinical trial of its lead drug candidate NBTX-001 in patients with panic ...
Breaking Biology Technology:
Cached News: